Please provide your email address to receive an email when new articles are posted on . A universal model predicted CV events for people with and without baseline atherosclerotic CVD. Some patients ...

Standard treatments can significantly lower the risk of stroke in children with sickle cell anemia, according to a review of ...

A risk calculator that incorporates established cardiovascular risk factors and additional cardiac biomarkers, such as high-sensitivity C-reactive protein (hs-CRP) and N-terminal pro-B-type ...

VESALIUS-CV was big in 2025, but studies looking at triglycerides, CRISPR, and oral GLP-1s also made the highlight reel.

The results may "reflect the fact that once a patient had an ASCVD event, they are subsequently well treated with secondary prevention medications such as antiplatelet agents and lipid-lowering ...

Hypertension control is critical to prevent stroke. With several clinical trials conducted over the last decade, it seems that the use of an angiotensin-modulating antihypertensive agent conveys ...

Please provide your email address to receive an email when new articles are posted on . PCSK9 inhibition demonstrated benefit in the broader primary prevention population for LDL lowering and plaque ...

NEW ORLEANS -- People with diabetes may be among those who still benefit from primary prevention aspirin, a large observational study suggested. In contrast with the unimpressive track record of ...